IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling

IL-37 has been characterized as a fundamental inhibitor of innate immunity and a tumor suppressor in several cancers. However, the molecular mechanism of IL-37 in hepatocellular carcinoma (HCC) is largely unclear. In this study we found IL-37 expression was down-regulated in human HCC tissues and ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Rui, Tang, Chengyong, Shen, Ai, Luo, Huating, Wei, Xufu, Zheng, Daofeng, Sun, Chao, Li, Zhongtang, Zhu, Di, Li, Tingting, Wu, Zhongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356721/
https://www.ncbi.nlm.nih.gov/pubmed/27835881
http://dx.doi.org/10.18632/oncotarget.13196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356721/
https://www.ncbi.nlm.nih.gov/pubmed/27835881
http://dx.doi.org/10.18632/oncotarget.13196

Ejemplares similares